Literature DB >> 21724730

Serum levels of HMGB1 in postmenopausal patients with rheumatoid arthritis: associations with proinflammatory cytokines, acute-phase reactants, and clinical disease characteristics.

Rille Pullerits, Vilma Urbonaviciute, Reinhard E Voll, Helena Forsblad-D'Elia, Hans Carlsten.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2011        PMID： 21724730     DOI： 10.3899/jrheum.110091

Source DB:  PubMed          Journal:  J Rheumatol        ISSN： 0315-162X            Impact factor:   4.666


× No keyword cloud information.
  11 in total

Review 1.  HMGB1: a multifunctional alarmin driving autoimmune and inflammatory disease.

Authors:  Helena Erlandsson Harris; Ulf Andersson; David S Pisetsky
Journal:  Nat Rev Rheumatol       Date:  2012-01-31       Impact factor: 20.543

2.  Nuclear DAMP complex-mediated RAGE-dependent macrophage cell death.

Authors:  Ruochan Chen; Sha Fu; Xue-Gong Fan; Michael T Lotze; Herbert J Zeh; Daolin Tang; Rui Kang
Journal:  Biochem Biophys Res Commun       Date:  2015-02-13       Impact factor: 3.575

Review 3.  HMGB1 in health and disease.

Authors:  Rui Kang; Ruochan Chen; Qiuhong Zhang; Wen Hou; Sha Wu; Lizhi Cao; Jin Huang; Yan Yu; Xue-Gong Fan; Zhengwen Yan; Xiaofang Sun; Haichao Wang; Qingde Wang; Allan Tsung; Timothy R Billiar; Herbert J Zeh; Michael T Lotze; Daolin Tang
Journal:  Mol Aspects Med       Date:  2014-07-08

Review 4.  Recent developments in the role of high-mobility group box 1 in systemic lupus erythematosus.

Authors:  Fleur Schaper; Johanna Westra; Marc Bijl
Journal:  Mol Med       Date:  2014-03-13       Impact factor: 6.354

Review 5.  The Effect and Regulatory Mechanism of High Mobility Group Box-1 Protein on Immune Cells in Inflammatory Diseases.

Authors:  Yun Ge; Man Huang; Yong-Ming Yao
Journal:  Cells       Date:  2021-04-28       Impact factor: 6.600

6.  Is serum HMGB1 a biomarker in ANCA-associated vasculitis?

Authors:  Alexandre de Souza; Johanna Westra; Johan Bijzet; Pieter C Limburg; Coen A Stegeman; Marc Bijl; Cees G M Kallenberg
Journal:  Arthritis Res Ther       Date:  2013       Impact factor: 5.156

7.  Low Soluble Receptor for Advanced Glycation End Products Precedes and Predicts Cardiometabolic Events in Women With Rheumatoid Arthritis.

Authors:  Mitra Nadali; Lovisa Lyngfelt; Malin C Erlandsson; Sofia Töyrä Silfverswärd; Karin M E Andersson; Maria I Bokarewa; Rille Pullerits
Journal:  Front Med (Lausanne)       Date:  2021-01-28

8.  HMGB1 and Its Hyperacetylated Isoform are Sensitive and Specific Serum Biomarkers to Detect Asbestos Exposure and to Identify Mesothelioma Patients.

Authors:  Andrea Napolitano; Daniel J Antoine; Laura Pellegrini; Francine Baumann; Ian Pagano; Sandra Pastorino; Chandra M Goparaju; Kirill Prokrym; Claudia Canino; Harvey I Pass; Michele Carbone; Haining Yang
Journal:  Clin Cancer Res       Date:  2016-01-05       Impact factor: 12.531

9.  The role of high mobility group box chromosomal protein 1 expression in the differential diagnosis of hepatic actinomycosis: a case report.

Authors:  Chuan-Xin Wu; Hui Guo; Jian-Ping Gong; Qi Liu; Hang Sun
Journal:  J Med Case Rep       Date:  2013-01-25

10.  Impact of serum high mobility group box 1 and soluble receptor for advanced glycation end-products on subclinical atherosclerosis in patients with granulomatosis with polyangiitis.

Authors:  Alexandre W S de Souza; Karina de Leeuw; Mirjan M van Timmeren; Pieter C Limburg; Coen A Stegeman; Marc Bijl; Johanna Westra; Cees G M Kallenberg
Journal:  PLoS One       Date:  2014-04-28       Impact factor: 3.240
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.